Literature DB >> 17043868

IgA and IgA-specific receptors in human disease: structural and functional insights into pathogenesis and therapeutic potential.

Michelle M Gomes1, Andrew B Herr.   

Abstract

IgA antibodies play an important role in humoral immunity. IgA is the predominant antibody in mucosal secretions and the second most prevalent in the serum. It occupies a unique position among human antibodies in that it can both trigger and suppress inflammatory responses, depending on the situation. Recent structural and functional studies have revealed details of the structure of IgA and its interaction with key cell-surface receptors. We look at the role IgA and IgA receptors (particularly FcalphaRI) play in the pathogenesis of diseases such as IgA nephropathy and other autoimmune conditions. Finally, we address the potential of IgA as a therapeutic tool to either trigger specific inflammatory responses to destroy target cells or suppress inflammatory responses in the case of autoimmune diseases, and the promise of mucosal vaccines for eliciting specific IgA responses to pathogens in mucosal environments.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17043868     DOI: 10.1007/s00281-006-0048-x

Source DB:  PubMed          Journal:  Springer Semin Immunopathol        ISSN: 0344-4325


  124 in total

1.  Crosslinking of the human Fc receptor for IgA (FcalphaRI/CD89) triggers FcR gamma-chain-dependent shedding of soluble CD89.

Authors:  G van Zandbergen; R Westerhuis; N K Mohamad; J G van De Winkel; M R Daha; C van Kooten
Journal:  J Immunol       Date:  1999-12-01       Impact factor: 5.422

2.  Identification of residues in the CH2/CH3 domain interface of IgA essential for interaction with the human fcalpha receptor (FcalphaR) CD89.

Authors:  R J Pleass; J I Dunlop; C M Anderson; J M Woof
Journal:  J Biol Chem       Date:  1999-08-13       Impact factor: 5.157

Review 3.  Dermatitis herpetiformis: problems, progress and prospects.

Authors:  Lionel Fry
Journal:  Eur J Dermatol       Date:  2002 Nov-Dec       Impact factor: 3.328

4.  Fine specificity of ligand-binding domain 1 in the polymeric Ig receptor: importance of the CDR2-containing region for IgM interaction.

Authors:  M Røe; I N Norderhaug; P Brandtzaeg; F E Johansen
Journal:  J Immunol       Date:  1999-05-15       Impact factor: 5.422

5.  Intracellular neutralization of virus by immunoglobulin A antibodies.

Authors:  M B Mazanec; C S Kaetzel; M E Lamm; D Fletcher; J G Nedrud
Journal:  Proc Natl Acad Sci U S A       Date:  1992-08-01       Impact factor: 11.205

6.  Increased N-linked glycosylation leading to oversialylation of monomeric immunoglobulin A1 from patients with Sjögren's syndrome.

Authors:  C Basset; V Durand; C Jamin; J Clément; Y Pennec; P Youinou; M Dueymes; I M Roitt
Journal:  Scand J Immunol       Date:  2000-03       Impact factor: 3.487

7.  Serum IgG, IgM, and IgA levels in ankylosing spondylitis.

Authors:  E M Veys; M van Leare
Journal:  Ann Rheum Dis       Date:  1973-11       Impact factor: 19.103

8.  Structure of the inhibitory receptor for human natural killer cells resembles haematopoietic receptors.

Authors:  Q R Fan; L Mosyak; C C Winter; N Wagtmann; E O Long; D C Wiley
Journal:  Nature       Date:  1997-09-04       Impact factor: 49.962

9.  Chimeric IgA antibodies against HLA class II effectively trigger lymphoma cell killing.

Authors:  Michael Dechant; Gestur Vidarsson; Bernhard Stockmeyer; Roland Repp; Martin J Glennie; Martin Gramatzki; Jan G J van De Winkel; Thomas Valerius
Journal:  Blood       Date:  2002-08-08       Impact factor: 22.113

10.  Cellular distribution, regulation, and biochemical nature of an Fc alpha receptor in humans.

Authors:  R C Monteiro; H Kubagawa; M D Cooper
Journal:  J Exp Med       Date:  1990-03-01       Impact factor: 14.307

View more
  7 in total

1.  The SCHOOL of nature: I. Transmembrane signaling.

Authors:  Alexander B Sigalov
Journal:  Self Nonself       Date:  2010-01

Review 2.  Immunoglobulin Glycosylation Effects in Allergy and Immunity.

Authors:  Alexandra Epp; Kathryn C Sullivan; Andrew B Herr; Richard T Strait
Journal:  Curr Allergy Asthma Rep       Date:  2016-11       Impact factor: 4.806

Review 3.  The role of the gut and microbes in the pathogenesis of spondyloarthritis.

Authors:  Mark Asquith; Dirk Elewaut; Phoebe Lin; James T Rosenbaum
Journal:  Best Pract Res Clin Rheumatol       Date:  2014-11-15       Impact factor: 4.098

4.  Analysis of IgA1 N-glycosylation and its contribution to FcalphaRI binding.

Authors:  Michelle M Gomes; Stephanie B Wall; Kazuo Takahashi; Jan Novak; Matthew B Renfrow; Andrew B Herr
Journal:  Biochemistry       Date:  2008-10-01       Impact factor: 3.162

5.  FCGR2C polymorphisms associate with HIV-1 vaccine protection in RV144 trial.

Authors:  Shuying S Li; Peter B Gilbert; Georgia D Tomaras; Gustavo Kijak; Guido Ferrari; Rasmi Thomas; Chul-Woo Pyo; Susan Zolla-Pazner; David Montefiori; Hua-Xin Liao; Gary Nabel; Abraham Pinter; David T Evans; Raphael Gottardo; James Y Dai; Holly Janes; Daryl Morris; Youyi Fong; Paul T Edlefsen; Fusheng Li; Nicole Frahm; Michael D Alpert; Heather Prentice; Supachai Rerks-Ngarm; Punnee Pitisuttithum; Jaranit Kaewkungwal; Sorachai Nitayaphan; Merlin L Robb; Robert J O'Connell; Barton F Haynes; Nelson L Michael; Jerome H Kim; M Juliana McElrath; Daniel E Geraghty
Journal:  J Clin Invest       Date:  2014-08-08       Impact factor: 14.808

6.  Clinical characteristics and favorable long-term outcomes for patients with idiopathic inflammatory myopathies: a retrospective single center study in China.

Authors:  Xiao Ming Shu; Xin Lu; Yao Xie; Guo Chun Wang
Journal:  BMC Neurol       Date:  2011-11-09       Impact factor: 2.474

Review 7.  SCHOOL model and new targeting strategies.

Authors:  Alexander B Sigalov
Journal:  Adv Exp Med Biol       Date:  2008       Impact factor: 2.622

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.